|
|
|
|
pmid:26718448
|
|
|
|
|
pmid:25908532
|
|
|
|
|
pmid:25890752
|
|
|
|
|
pmid:24929111
|
|
|
|
|
pmid:27573422
|
|
|
|
|
pmid:26638987
|
|
|
|
|
pmid:26630551
|
|
|
|
|
pmid:29095817
|
|
|
|
|
pmid:27559094
|
|
|
|
|
pmid:26597784
|
|
|
|
|
pmid:27508346
|
|
|
|
|
pmid:25806690
|
|
|
|
|
pmid:24784707
|
|
|
|
|
pmid:28779028
|
|
|
|
|
pmid:26550951
|
|
|
|
|
pmid:28694292
|
|
|
|
|
pmid:28610917
|
|
|
|
|
pmid:28584076
|
|
|
|
|
pmid:26531230
|
|
|
|
|
pmid:27362771
|
|
|
|
|
pmid:26492476
|
|
|
|
|
pmid:28442547
|
|
|
|
|
pmid:27317426
|
|
|
|
|
pmid:24571866
|
|
|
|
|
pmid:24451959
|
|
|
|
|
pmid:28322829
|
|
|
|
|
pmid:26335632
|
|
|
|
|
pmid:28237084
|
|
|
|
|
pmid:28218420
|
|
|
|
|
pmid:25453942
|
|
|
|
|
pmid:27044027
|
|
|
|
|
pmid:22610993
|
|
|
|
|
pmid:27034112
|
|
|
|
|
pmid:26927755
|
|
|
|
|
pmid:26159746
|
|
|
|
|
pmid:25218162
|
|
|
|
|
pmid:26118631
|
|
|
|
|
pmid:25123641
|
|
|
|
|
pmid:26808633
|
|
|
|
|
pmid:27133431
|
|
|
|
|
pmid:25030943
|
|
|
|
|
pmid:
|
Wang X et al. |
Resolution of inflammation is altered in Alzheimer's disease. |
2015 |
Alzheimers Dement |
pmid:24530025
|
Hsiao HM et al. |
Resolvin D1 Reduces Emphysema and Chronic Inflammation. |
2015 |
Am. J. Pathol. |
pmid:26468975
|
Krishnamoorthy S et al. |
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. |
2012 |
Am. J. Pathol. |
pmid:22449948
|
Liu Y et al. |
Resolvin D1 protects against inflammation in experimental acute pancreatitis and associated lung injury. |
2016 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:26702138
|
Hiram R et al. |
Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery. |
2014 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:25281570
|
Croasdell A et al. |
Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. |
2015 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:26301452
|
Orr SK et al. |
Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. |
2015 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:25770181
|
Hiram R et al. |
Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries. |
2015 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:26320154
|
Shinohara M et al. |
Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. |
2014 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:25217660
|
Mustafa M et al. |
Resolvin D1 protects periodontal ligament. |
2013 |
Am. J. Physiol., Cell Physiol. |
pmid:23864609
|
Odusanwo O et al. |
Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation. |
2012 |
Am. J. Physiol., Cell Physiol. |
pmid:22237406
|
Nelson JW et al. |
ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. |
2014 |
Am. J. Physiol., Cell Physiol. |
pmid:24259417
|
Cox R et al. |
Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment. |
2015 |
Am. J. Respir. Cell Mol. Biol. |
pmid:25647402
|
Wendel M and Heller AR |
Anticancer actions of omega-3 fatty acids--current state and future perspectives. |
2009 |
Anticancer Agents Med Chem |
pmid:19442044
|
Norling LV et al. |
Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22499990
|
Prieto P et al. |
Activation of autophagy in macrophages by pro-resolving lipid mediators. |
2015 |
Autophagy |
pmid:26506892
|
Fredman G and Serhan CN |
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. |
2011 |
Biochem. J. |
pmid:21711247
|
Lee HN and Surh YJ |
Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. |
2013 |
Biochem. Pharmacol. |
pmid:23856291
|
de Oliveira JR et al. |
AT-RvD1 modulates CCL-2 and CXCL-8 production and NF-κB, STAT-6, SOCS1, and SOCS3 expression on bronchial epithelial cells stimulated with IL-4. |
2015 |
Biomed Res Int |
pmid:26075216
|
Lim JY et al. |
Biological Roles of Resolvins and Related Substances in the Resolution of Pain. |
2015 |
Biomed Res Int |
pmid:26339646
|
Dalli J and Serhan CN |
Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. |
2012 |
Blood |
pmid:22904297
|
Quan-Xin F et al. |
Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn. |
2012 |
BMC Gastroenterol |
pmid:23092159
|
Spite M et al. |
Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. |
2009 |
Br. J. Pharmacol. |
pmid:19422383
|
Bang S et al. |
17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. |
2012 |
Br. J. Pharmacol. |
pmid:21718307
|
Bang S et al. |
Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. |
2010 |
Br. J. Pharmacol. |
pmid:20880407
|
Lima-Garcia JF et al. |
The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. |
2011 |
Br. J. Pharmacol. |
pmid:21418187
|
Filep JG |
Lipid mediator interplay: resolvin D1 attenuates inflammation evoked by glutathione-conjugated lipid peroxidation products. |
2009 |
Br. J. Pharmacol. |
pmid:19845687
|
Harrison JL et al. |
Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. |
2015 |
Brain Behav. Immun. |
pmid:25585137
|
Zhao YL et al. |
Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis. |
2016 |
Chin. Med. J. |
pmid:27098797
|
Mas E et al. |
Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. |
2012 |
Clin. Chem. |
pmid:22912397
|
Xu MX et al. |
Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. |
2013 |
CNS Neurosci Ther |
pmid:23521911
|
Tang Y et al. |
Proresolution therapy for the treatment of delayed healing of diabetic wounds. |
2013 |
Diabetes |
pmid:23043160
|
Koltsida O et al. |
Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. |
2013 |
EMBO Mol Med |
pmid:23584892
|
Chen F et al. |
Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response. |
2014 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:24072678
|
Kim N et al. |
Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production. |
2016 |
Eur. J. Immunol. |
pmid:26474728
|
Schif-Zuck S et al. |
Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. |
2011 |
Eur. J. Immunol. |
pmid:21268007
|
Haworth O and Levy BD |
Endogenous lipid mediators in the resolution of airway inflammation. |
2007 |
Eur. Respir. J. |
pmid:17978156
|
Kaarniranta K and Salminen A |
NF-kappaB signaling as a putative target for omega-3 metabolites in the prevention of age-related macular degeneration (AMD). |
2009 |
Exp. Gerontol. |
pmid:19751815
|
Lehmann C et al. |
Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein. |
2015 |
FASEB J. |
pmid:26289316
|
Fiala M et al. |
ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. |
2015 |
FASEB J. |
pmid:25805829
|
Dalli J et al. |
Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. |
2015 |
FASEB J. |
pmid:25713027
|
Lastrucci C et al. |
Molecular and cellular profiles of the resolution phase in a damage-associated molecular pattern (DAMP)-mediated peritonitis model and revelation of leukocyte persistence in peritoneal tissues. |
2015 |
FASEB J. |
pmid:25609430
|
Kurihara T et al. |
Resolvin D2 restores neutrophil directionality and improves survival after burns. |
2013 |
FASEB J. |
pmid:23430978
|
Miyahara T et al. |
D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. |
2013 |
FASEB J. |
pmid:23407709
|
Hellmann J et al. |
Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. |
2011 |
FASEB J. |
pmid:21478260
|
Terrando N et al. |
Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. |
2013 |
FASEB J. |
pmid:23709617
|
Recchiuti A et al. |
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. |
2014 |
FASEB J. |
pmid:24692596
|
Recchiuti A et al. |
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. |
2011 |
FASEB J. |
pmid:20956612
|
Merched AJ et al. |
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. |
2008 |
FASEB J. |
pmid:18559988
|
Rius B et al. |
Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. |
2014 |
FASEB J. |
pmid:24249635
|
Chung ML et al. |
Profiling of oxidized lipid products of marine fish under acute oxidative stress. |
2013 |
Food Chem. Toxicol. |
pmid:23220612
|
Weylandt KH et al. |
Lipoxins and resolvins in inflammatory bowel disease. |
2007 |
Inflamm. Bowel Dis. |
pmid:17262807
|
Benabdoune H et al. |
The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. |
2016 |
Inflamm. Res. |
pmid:27056390
|
Zhao Q et al. |
Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in Rats. |
2016 |
Inflammation |
pmid:27145782
|
Gu Z et al. |
Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes. |
2016 |
Innate Immun |
pmid:26878867
|
Kim KH et al. |
Resolvin D1 prevents smoking-induced emphysema and promotes lung tissue regeneration. |
2016 |
Int J Chron Obstruct Pulmon Dis |
pmid:27313451
|
Lee HJ et al. |
Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. |
2013 |
Int. J. Biochem. Cell Biol. |
pmid:24120851
|
Jin Y et al. |
Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. |
2009 |
Invest. Ophthalmol. Vis. Sci. |
pmid:19407006
|